{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T03:51:59Z","timestamp":1768449119150,"version":"3.49.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T00:00:00Z","timestamp":1572220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Stereotactic body radiotherapy has emerged as an attractive alternative to conventional radiotherapy for spinal metastases. However, it has limitations, including the need for advanced techniques and specific adverse effects. The present trial aimed to validate the feasibility and safety of stereotactic body radiotherapy in Japanese patients with spinal metastases.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Patients with one or two spinal metastases received stereotactic body radiotherapy of 24\u00a0Gy in two fractions. The primary endpoint was the proportion of severe adverse effects (\u2265 grade 3) in patients within 6\u00a0months after spine stereotactic body radiotherapy. Adverse effects were evaluated according to the National Cancer Institute Common Terminology Criteria for Adverse Events version 4. The treatment protocol was considered feasible and tolerable if the proportion of severe adverse effects was 10% or less.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Overall, 20 spinal segments in 20 patients who registered between March 2014 and October 2015 were included. Minor and major deviations were observed in the planning of 2 and 0 cases, respectively. The treatment completion rate was 100%. The median follow-up after registration was 24.5 (range: 1\u201361) months. Although four patients experienced acute grade 2 adverse effects, no grade 3 or higher adverse effects were observed within 6\u00a0months after spine stereotactic body radiotherapy. Vertebral compression fractures were observed in two patients (14 and 16\u00a0months after stereotactic body radiotherapy). The local control and pain response rates at 6\u00a0months were 100 and 83%, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This study demonstrated the feasibility and safety of spine stereotactic body radiotherapy in Japanese patients with spinal metastases.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jjco\/hyz130","type":"journal-article","created":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T12:12:22Z","timestamp":1564747942000},"page":"999-1003","source":"Crossref","is-referenced-by-count":8,"title":["A prospective multicentre feasibility study of stereotactic body radiotherapy in Japanese patients with spinal metastases"],"prefix":"10.1093","volume":"49","author":[{"given":"Kei","family":"Ito","sequence":"first","affiliation":[{"name":"Division of Radiation Oncology, Department of Radiology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohisa","family":"Furuya","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology, Department of Radiology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Shikama","sequence":"additional","affiliation":[{"name":"Department of Radiology, Juntendo University, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Nihei","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology, Department of Radiology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Kumazaki","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Saitama Medical University International Medical Center, Hidaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Shion Daini Clinic, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuyuki","family":"Karasawa","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology, Department of Radiology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,10,28]]},"reference":[{"key":"2019122810174061400_ref1","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2010.11.026","article-title":"Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline","volume":"79","author":"Lutz","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2019122810174061400_ref2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.clon.2011.11.004","article-title":"Update on the systematic review of palliative radiotherapy trials for bone metastases","volume":"24","author":"Chow","year":"2012","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2019122810174061400_ref3","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s007010050199","article-title":"Surgical results for spinal metastases","volume":"140","author":"Klekamp","year":"1998","journal-title":"Acta Neurochir"},{"key":"2019122810174061400_ref4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0167-8140(99)00097-3","article-title":"8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up","volume":"52","author":"Bone Pain Trial Working Party","year":"1999","journal-title":"Radiother Oncol"},{"key":"2019122810174061400_ref5","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.ijrobp.2006.07.1383","article-title":"Update of human spinal cord reirradiation tolerance based on additional data from 38 patients","volume":"66","author":"Nieder","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2019122810174061400_ref6","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.prro.2013.05.001","article-title":"RTOG 0631 phase 2\/3 study of image guided stereotactic radiosurgery for localized (1-3) spine metastases: phase 2 results","volume":"4","author":"Ryu","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"2019122810174061400_ref7","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1748-717X-8-158","article-title":"A multi-national report on methods for institutional credentialing for spine radiosurgery","volume":"8","author":"Gerszten","year":"2013","journal-title":"Radiat Oncol"},{"key":"2019122810174061400_ref8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/neuros\/nyx493","article-title":"Vertebral compression fracture after spine stereotactic body radiation therapy: a review of the pathophysiology and risk factors","volume":"83","author":"Faruqi","year":"2018","journal-title":"Neurosurgery"},{"key":"2019122810174061400_ref9","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.ijrobp.2014.07.037","article-title":"Incidence and predictive factors of pain flare after spine stereotactic body radiation therapy: secondary analysis of phase 1\/2 trials","volume":"90","author":"Pan","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2019122810174061400_ref10","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.3171\/2016.11.FOCUS16348","article-title":"Peripheral nervous system injury after high-dose single-fraction image-guided stereotactic radiosurgery for spine tumors","volume":"42","author":"Stubblefield","year":"2017","journal-title":"Neurosurg Focus"},{"key":"2019122810174061400_ref11","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.ijrobp.2011.02.019","article-title":"Recursive partitioning analysis index is predictive for overall survival in patients undergoing spine stereotactic body radiation therapy for spinal metastases","volume":"82","author":"Chao","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2019122810174061400_ref12","doi-asserted-by":"crossref","first-page":"E1221","DOI":"10.1097\/BRS.0b013e3181e16ae2","article-title":"A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the spine oncology study group","volume":"35","author":"Fisher","year":"2010","journal-title":"Spine (Phila Pa 1976)"},{"key":"2019122810174061400_ref13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3171\/2010.3.SPINE09639","article-title":"Local disease control after decompressive surgery and adjuvant high-dose single-fraction radiosurgery for spine metastases","volume":"13","author":"Moulding","year":"2010","journal-title":"J Neurosurg Spine"},{"key":"2019122810174061400_ref14","doi-asserted-by":"crossref","first-page":"e597","DOI":"10.1016\/j.ijrobp.2012.03.009","article-title":"International spine radiosurgery consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery","volume":"83","author":"Cox","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2019122810174061400_ref15","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: the report of AAPM task group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"key":"2019122810174061400_ref16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijrobp.2012.05.007","article-title":"Probabilities of radiation myelopathy specific to stereotactic body radiation therapy to guide safe practice","volume":"85","author":"Sahgal","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2019122810174061400_ref17","author":"Common Terminology Criteria for Adverse Events Version"},{"key":"2019122810174061400_ref18","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.ijrobp.2011.02.008","article-title":"Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases","volume":"82","author":"Chow","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2019122810174061400_ref19","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"2019122810174061400_ref20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3171\/2017.1.SPINE16684","article-title":"Stereotactic body radiotherapy for de novo spinal metastases: systematic review. International Stereotactic Radiosurgery Society practice guidelines","volume":"27","author":"Husain","year":"2017","journal-title":"J Neurosurg Spine"},{"key":"2019122810174061400_ref21","article-title":"Conventional with stereotactic radiotherapy for pain reduction and quality of life in spinal metastases (RACOST)"},{"key":"2019122810174061400_ref22","article-title":"Image-guided radiosurgery or stereotactic body radiation therapy in treating patients with localized spine metastasis"},{"key":"2019122810174061400_ref23","article-title":"Randomized phase II\/III trial of stereotactic body radiotherapy versus conventional multi-fractional radiotherapy for spine metastases"},{"key":"2019122810174061400_ref24","article-title":"Study comparing stereotactic body radiotherapy vs conventional palliative radiotherapy (CRT) for spinal metastases"},{"key":"2019122810174061400_ref25","first-page":"307","article-title":"Evaluating dosimetric differences in spine stereotactic body radiotherapy: an international multi-institutional treatment planning study","volume":"3","author":"Furuya","year":"2015","journal-title":"J Radiosurg SBRT"},{"key":"2019122810174061400_ref26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.prro.2018.05.006","article-title":"Assessing functionality and benefits of comprehensive dose volume prescriptions: an international, multi-institutional, treatment planning study in spine stereotactic body radiation therapy","volume":"9","author":"Furuya","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"2019122810174061400_ref27","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.ijrobp.2009.10.003","article-title":"Correlation of local failure with measures of dose insufficiency in the high-dose single-fraction treatment of bony metastases","volume":"77","author":"Lovelock","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2019122810174061400_ref28","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.ijrobp.2015.03.037","article-title":"Outcomes for spine stereotactic body radiation therapy and an analysis of predictors of local recurrence","volume":"92","author":"Bishop","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2019122810174061400_ref29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijrobp.2015.05.035","article-title":"Five-year outcomes of high-dose single-fraction spinal stereotactic radiosurgery","volume":"93","author":"Moussazadeh","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/49\/11\/999\/31630314\/hyz130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/49\/11\/999\/31630314\/hyz130.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,28]],"date-time":"2019-12-28T15:17:55Z","timestamp":1577546275000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/49\/11\/999\/5607889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,28]]},"references-count":29,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,10,28]]},"published-print":{"date-parts":[[2019,12,18]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyz130","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,11]]},"published":{"date-parts":[[2019,10,28]]}}}